InceptionR’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,195
Closed -$465K 748
2025
Q2
$465K Buy
+1,195
New +$481K 0.11% 335
2025
Q1
Sell
-3,885
Closed -$1.43M 626
2024
Q4
$1.43M Buy
3,885
+2,562
+194% +$1.07M 0.32% 81
2024
Q3
$688K Buy
+1,323
New +$707K 0.17% 239
2024
Q2
Sell
-3,323
Closed -$1.72M 662
2024
Q1
$1.72M Buy
3,323
+1,421
+75% +$707K 0.44% 24
2023
Q4
$897K Buy
+1,902
New +$879K 0.64% 1
2023
Q3
Sell
-979
Closed -$435K 446
2023
Q2
$435K Sell
979
-151
-13% -$69.7K 0.23% 174
2023
Q1
$520K Buy
1,130
+573
+103% +$273K 0.17% 236
2022
Q4
$286K Buy
+557
New +$283K 0.15% 289

Other funds holding ELV

InceptionR's ELV Position: Q3 2025 in Review

InceptionR sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,195 shares — an estimated $465K sold.

InceptionR first reported a position in ELV in Q4 2022 and held it in 8 quarters. The position peaked at $1.72M in Q1 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • InceptionR reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • InceptionR sold 1,195 Elevance Health shares in Q3 2025, an estimated $465K.
  • InceptionR first reported a position in Elevance Health in Q4 2022 and held it in 8 quarters.
  • InceptionR's Elevance Health position peaked at $1.72M in Q1 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on InceptionR's 13F filing for Q3 2025, filed 13 Nov 2025.